TENAX THERAPEUTICS, INC. Deferred Federal Income Tax Expense (Benefit)
TENAX THERAPEUTICS, INC. (TENX) reported Deferred Federal Income Tax Expense (Benefit) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2018-04-02
- TENAX THERAPEUTICS, INC. deferred federal income tax expense (benefit) for fiscal 2017 was $0.00.
- TENAX THERAPEUTICS, INC. deferred federal income tax expense (benefit) for fiscal 2016 was -$7.14M.
- TENAX THERAPEUTICS, INC. deferred federal income tax expense (benefit) for fiscal 2015 was $0.00.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 |
| 2016-12-31 | -$7.14M 10-K · filed 2018-04-02 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |